HSBC Adjusts Price Target on IQVIA to $290 From $280
BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $275
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $251 to $300
IQVIA Holdings Price Target Raised to $251.00/Share From $235.00 by Baird
IQVIA Hldgs Analyst Ratings
Evercore ISI Adjusts Price Target on IQVIA Holdings to $270 From $230, Maintains Outperform Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)
IQVIA Holdings: Strong Q2 Performance and Raised Annual Guidance Prompt 'Buy' Rating
Barclays Sticks to Its Buy Rating for IQVIA Holdings (IQV)
IQVIA Holdings: Strong H2 Outlook With Buoyant TAS, RWE, and RDS Segments Driving Buy Rating
Stifel Adjusts IQVIA Holdings' Price Target to $312 From $288
IQVIA Hldgs Analyst Ratings
Evercore ISI Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Outperform Rating
IQVIA Hldgs Analyst Ratings
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275
IQVIA Hldgs Analyst Ratings
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target
IQVIA Holdings (IQV) Gets a Buy From Jefferies
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)